DAVID JUNKIN | WHAT’S BEHIND THE BIOTECH SECTOR’S REBOUND FOR THE WALL STREET JOURNAL
Here’s a great piece by DAVID JUNKIN for The Wall Street Journal! The article is called “What’s Behind the Biotech Sector’s Rebound: Biotech ETFs has investors’ hearts pumping again. Fund buying after Donald Trump’s election helped. The Nasdaq Biotechnology Index fell 21% in 2016 but is up 11% so far in 2017. …
Tags: bioteach, biotech sector, biotech stocks, biotechnology index, david junkin, ETF's, finance, funds, Investors, Mutual Funds, nasdaq